Wai Yuen Tong Medicine Holdings Limited provided unaudited consolidated earnings guidance for the six months ended September 30, 2021. For the six months, the Group is expected to record a profit attributable to owners of the parent of not less than approximately HKD 10 million for the six months ended 30 September 2021 as compared with a loss attributable to owners of the parent for the six months ended 30 September 2020 of approximately HKD 233.2 million as published in 2020 interim report.